SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve financial results for the quarter and half year ended September 30, 2026

October 15, 2026 SBIL/CS/NSE-BSE/2627/119 Vice President General Manager Listing Department, Listing Department, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, BKC, Dalal Street, Bandra (East), Mumbai 400051 Mumbai 400001 NSE Symbol: SBILIFE BSE Scrip Code: 540719 Dear Sir / Madam, Subject: Intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) We wish to inform you that meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, October 27, 2026 to consider and approve financial results for the quarter and half year ended September 30, 2026. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and in continuation to our letter dated September 30, 2026 bearing reference number SBIL/CS/NSE-BSE/2627/107, the trading window will remain closed from October 01, 2026 and will reopen 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026. You are requested to kindly take the same on record. Thanking you, Yours faithfully, Girish Manik Company Secretary ACS No. 26391 Public SBI Life Insurance Company Ltd. Registered and Corporate Office: Natraj, M.V. Road and Western Express Highway Junction Andheri (East), Mumbai 400 069. Tel.: (022) 6191 0000/ 3968 0000 IRDAI Regn. No. 111. CIN: L99999MH2000PLC129113 www.sbilife.co.in